Breast Cancer Prevention: A Dialog Among Medical Experts, Researchers, and Start-ups

Thumbnail

Event details

Date 12.05.2025
Hour 15:0018:00
Speaker Cathrin BRISKEN : Associate Professor, ISREC, School of Life Sciences, EPFL, the Breast Cancer Now Toby Robins Research Center, the Institute of Cancer Research London, UK Stéphanie LACOUR: VP for Support to Strategic Initiatives, EPFL Dr. Khalid ZAMAN: Assistant Physician, Head of Breast Cancer Center, Department of Oncology, UNIL, CHUV Wolfgang HACKL: Founder & CEO of OncogenomX
Location
Rolex Learning Center
Category Conferences - Seminars
Event Language English

Did you know that breast cancer is the most frequently diagnosed cancer worldwide? More than 70% of breast cancers are sensitive to hormones. The body’ own hormones as well as hormone preparations taken by women have a role in breast cancer development. Both hormone-based contraception and hormone replacement therapy used to combat symptoms associated with menopause increase the risk to get breast cancer. Throughout our lives we are exposed to hormonally active substances. 

EPFL Innovation Park and Groupe Mutuel are proud to welcome Prof. Cathrin Brisken as the keynote speaker of the 5th Tech4Eva Opening Conference, taking place on May 12, 2025, virtually and in person at the Rolex Forum in Lausanne.

Prof. Cathrin Brisken is internationally recognized for her work on endocrine control of mammary gland development and breast carcinogenesis. During her talk, she will highlight how breast cancer can be prevented by blocking hormones. 
Research in Dr. Brisken’s laboratories focuses on the cellular and molecular underpinnings of estrogen, progesterone, and androgen receptor signaling in the breast epithelium and the respective roles of these hormones and hormonally active compounds in carcinogenesis. The aim is to understand how recurrent exposures to endogenous and exogenous hormones contribute to breast carcinogenesis in order to better prevent and treat the disease. Find out more about her research during her talk.

Following the keynote, Tech4Eva will unveil the 2025 cohort—a selection of innovative Femtech start-ups joining our equity-free global accelerator program.

What to expect:
-Gain Knowledge on the latest trends advancing women's health from the leading innovators;
-Find Femtech solutions, investment and partnership opportunities;
-Expand your research and Femtech business network;
-Discover and meet the disruptive Tech4Eva's start-ups 2025; and
-Be inspired to create tomorrow's innovative solutions in women's health! 
Build a new future together with us to create better women’s healthcare for tomorrow! Join us May 12th.

Check out Tech4Eva's website for the full agenda and speaker lineup! 

Practical information

  • General public
  • Free

Contact

  • Simone Theiss, Program Manager of Tech4Eva: theiss@epfl-innovationpark.ch

Tags

Femtech

Share